Cumberland Pharmaceuticals, Inc. (CPIX)
7.39
-0.12
(-1.60%)
USD |
NASDAQ |
Oct 02, 16:00
7.39
0.00 (0.00%)
After-Hours: 20:00
Cumberland Pharmaceuticals Price to Book Value : 6.350 for Oct. 2, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 02, 2026 | 6.350 |
| October 01, 2026 | 6.453 |
| September 30, 2026 | 6.728 |
| September 29, 2026 | 6.573 |
| September 28, 2026 | 6.633 |
| September 25, 2026 | 6.539 |
| September 24, 2026 | 6.882 |
| September 23, 2026 | 6.822 |
| September 22, 2026 | 7.046 |
| September 21, 2026 | 6.522 |
| September 18, 2026 | 6.290 |
| September 17, 2026 | 6.178 |
| September 16, 2026 | 5.997 |
| September 15, 2026 | 5.705 |
| September 14, 2026 | 5.757 |
| September 11, 2026 | 5.490 |
| September 10, 2026 | 5.568 |
| September 09, 2026 | 5.404 |
| September 08, 2026 | 5.688 |
| September 04, 2026 | 5.834 |
| September 03, 2026 | 5.800 |
| September 02, 2026 | 5.602 |
| September 01, 2026 | 5.636 |
| August 31, 2026 | 5.748 |
| August 28, 2026 | 7.269 |
| Date | Value |
|---|---|
| August 27, 2026 | 7.432 |
| August 26, 2026 | 7.707 |
| August 25, 2026 | 7.475 |
| August 24, 2026 | 6.736 |
| August 21, 2026 | 6.573 |
| August 20, 2026 | 6.444 |
| August 19, 2026 | 6.573 |
| August 18, 2026 | 6.556 |
| August 17, 2026 | 6.599 |
| August 14, 2026 | 6.693 |
| August 13, 2026 | 6.788 |
| August 12, 2026 | 6.796 |
| August 11, 2026 | 6.839 |
| August 10, 2026 | 6.693 |
| August 07, 2026 | 6.702 |
| August 06, 2026 | 6.599 |
| August 05, 2026 | 6.487 |
| August 04, 2026 | 6.676 |
| August 03, 2026 | 6.169 |
| July 31, 2026 | 5.740 |
| July 30, 2026 | 5.783 |
| July 29, 2026 | 5.722 |
| July 28, 2026 | 5.851 |
| July 27, 2026 | 6.040 |
| July 24, 2026 | 5.680 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ANI Pharmaceuticals, Inc. | 2.776 |
| Corcept Therapeutics, Inc. | 17.77 |
| Veru, Inc. | 1.508 |
| Johnson & Johnson | 7.256 |
| Eli Lilly & Co. | 31.76 |
Price to Book Value Related Metrics
| PS Ratio | 3.537 |
| PEG Ratio | -0.0419 |
| Price to Free Cash Flow | 177.22 |
| Price | 7.39 |
| Earnings Yield | -9.87% |
| Market Cap | 110.73M |
| PEGY Ratio | -0.0419 |